2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Consolidation of learning and memory in Parkinson’s disease

M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy (New York City, NY, USA)
Constant-current stimulation in Parkinson’s disease patients

P. Amami, M. Mascia, L. Romito, A. Albanese (Rozzano, Italy)
Constipation in early de novo Parkinson’s disease: Prevalence and correlates with clinical features, imaging and non-imaging biomarkers

G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)
Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia

B.E. Muñoz, O. Bernal, A. Castillo, J.L. Orozco (Cali, Colombia)
Construction of a levodopa-response index from wearable sensors for quantifying Parkinson’s disease motor functions: Preliminary results

M. Memedi, D. Nyholm, J. Westin, M. Senek, A. Medvedev, H. Askmark, S.M. Aquilonius, F. Bergquist, R. Constantinescu, F. Ohlsson, J. Spira, S. Lycke, A. Ericsson (Falun, Sweden)
Consumption of Yerba Mate (Ilex Paraguariensis) in Parkinson’s disease patients from Uruguay

I. Amorín, A. Lescano, N. Ramírez, V. Raggio, R. Buzó (Montevideo, Uruguay)
Continuous subcutaneous delivery of solubilized carbidopa improves the pharmacokinetic profile of levodopa

R. Shaltiel-Karyo, E. Zawoznik, I. Weinstock, M. Nemas, Y. Caraco, P.A. LeWitt, S. Oren, O. Yacoby-Zeevi (Rehovot, Israel)
Contributions of sensorial feedback to gait in Parkinson’s disease

F.A. Barbieri, L.T.B. Gobbi, P.C.R. Santos, R. Vitório, L. Simieli, D. Orcioli-Silva, M.B. Pestana, C.M. Fiorelli, Q. Almeida (Bauru, Brazil)
Conversion of patients from immediate release carbidopa-levodopa (IR CD-LD) and sustained release carbidopa-levodopa (SR CD-LD) to extended-release carbidopa-levodopa (ER CD-LD) in clinical practice

S.J. LoRusso, B. Ouyang, B.R. Barton (Chicago, IL, USA)
Conversion to IPX066, extended-release carbidopa-levodopa, in advanced Parkinson’s disease patients: Dosing patterns

J. Morgan, M. Stacy, R. Rubens, S. Khanna, S. Gupta (Augusta, GA, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z